Every material Form 8-K Protolabs has filed with the SEC since October 07, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Protolabs reported record third-quarter 2026 revenue of $154.3 million, up 14.0% year over year, and GAAP diluted earnings per share of $0.48, up from $0.30. The company raised its full-year 2026 revenue growth guidance to 10% to 11% and expects fourth-quarter revenue of $143.0 million to $151.0 million, which gives shareholders a higher outlook alongside higher quarterly profit.
Q3 2026 revenue was a record $154.3 million, up 14.0% from the third quarter of 2025.
GAAP diluted EPS was $0.48 versus $0.30; non-GAAP diluted EPS was $0.63 versus $0.47.
Full-year 2026 revenue growth guidance raised to 10% to 11% from 8% to 10%.
Q4 2026 guidance: revenue of $143.0 million to $151.0 million; GAAP diluted EPS of $0.28 to $0.36.
Protolabs reported record second quarter 2026 revenue of $149.3 million, up 10.6% from a year earlier, and GAAP diluted EPS of $0.37 versus $0.18 in the prior-year quarter. The company raised its full-year 2026 revenue growth guidance to 8% to 10%, from 6% to 8%, and gave third-quarter revenue guidance of $145.0 million to $153.0 million.
Q2 2026 revenue was a record $149.3 million, up 10.6% year-over-year; GAAP net income was $9,152 thousand, versus $4,427 thousand a year earlier
Non-GAAP diluted EPS was $0.60 versus $0.41 in Q2 2025; GAAP diluted EPS was $0.37 versus $0.18
Full-year 2026 revenue growth guidance raised to 8% to 10%, from 6% to 8%
Q3 2026 outlook: revenue of $145.0 million to $153.0 million and GAAP diluted EPS of $0.34 to $0.42
At its May 19, 2026 annual meeting, Proto Labs shareholders elected all seven board nominees, ratified Ernst & Young LLP as auditor for 2026, and approved an advisory vote on executive pay. They also approved an amendment adding 395,000 shares to the 2022 Long-Term Incentive Plan. The company will hold advisory pay votes annually, following the one-year frequency that shareholders selected.
Shareholders approved adding 395,000 shares to the 2022 Long-Term Incentive Plan, with 18,788,716 votes for and 456,309 against.
Ernst & Young LLP was ratified as the independent auditor for the fiscal year ending December 31, 2026, with 20,526,343 votes for and 431,696 against.
Advisory say-on-pay passed with 15,830,565 votes for and 3,405,377 against; shareholders chose one year as the vote frequency, with 17,972,937 votes.
Director Archie C. Black received the most against votes among nominees, at 3,169,101.
Protolabs appointed Bernardo Parlange as its newly created Chief Commercial Officer, effective May 18, 2026, and said COO Mike Kenison will retire effective July 1, 2026. The filing discloses leadership changes only and does not include financial results or guidance.
Parlange will oversee global commercial strategy, including sales, marketing, and customer success.
Parlange was most recently Senior Vice President of Sales & Marketing at Fortrex, a Blackstone portfolio company.
Kenison joined Protolabs in 2006 and retires as Chief Operations Officer effective July 1, 2026.
The announcement was made in a press release dated May 7, 2026, filed as Exhibit 99.1.
Proto Labs reported first quarter 2026 revenue of $139.3 million, up 10.4% from a year earlier, and GAAP net income of $8.1 million, or $0.33 per diluted share, compared with $3.6 million, or $0.15, in the first quarter of 2025. The company also guided to second quarter 2026 revenue of $140.0 million to $148.0 million and full-year 2026 revenue growth of 6% to 8%.
Revenue was $139.3 million, up 10.4% from $126.2 million in Q1 2025; CNC Machining revenue grew 19.7%.
GAAP diluted EPS was $0.33 versus $0.15 a year earlier; non-GAAP diluted EPS was $0.54 versus $0.33.
Adjusted EBITDA was $22.8 million, or 16.3% of revenue, compared with $17.4 million, or 13.8%, in Q1 2025.
Q2 2026 outlook: revenue of $140.0 million to $148.0 million and non-GAAP diluted EPS of $0.50 to $0.58; full-year 2026 revenue growth of 6% to 8%.
Proto Labs reported record fourth-quarter 2025 revenue of $136.5 million, up 12.1% year over year, and swung to net income of $6.0 million, or $0.25 per diluted share, from a net loss a year earlier. For full year 2025, revenue rose 6.4% to a record $533.1 million and diluted EPS was $0.88, but the company guided to 6% to 8% revenue growth for 2026, with Q1 2026 revenue expected between $130.0 million and $138.0 million.
Q4 2025 revenue was $136.5 million, up 12.1%; CNC Machining revenue rose 25.0%.
Q4 2025 diluted EPS was $0.25, versus a loss of $0.02 per share in Q4 2024.
Full year 2025 revenue was $533.1 million, up 6.4%; diluted EPS was $0.88, versus $0.66 in 2024.
2026 outlook: revenue growth of 6% to 8% for fiscal 2026; Q1 2026 revenue of $130.0 million to $138.0 million.
Proto Labs reported record third quarter 2025 revenue of $135.4 million, up 7.8% from a year earlier, while GAAP and non-GAAP earnings per share were flat at $0.30 and $0.47. The company guided fourth quarter 2025 revenue to $125.0 million to $133.0 million, below the third quarter level, with non-GAAP diluted EPS of $0.30 to $0.38.
Q3 2025 revenue $135.4 million, up 7.8% from $125.6 million; CNC Machining revenue rose to $63.0 million from $53.3 million
GAAP diluted EPS $0.30 vs $0.29 a year earlier; non-GAAP diluted EPS $0.47, unchanged
Adjusted EBITDA $21.1 million (15.6% margin) vs $21.9 million (17.4% margin) in Q3 2024
Q4 2025 outlook: revenue $125.0 million to $133.0 million; GAAP diluted EPS $0.12 to $0.20
Proto Labs said its chief technology officer, Oleg Ryaboy, will leave the company effective November 2, 2025, and that Marc Kermisch will take over as Chief Technology & AI Officer effective October 13, 2025. Ryaboy will receive severance benefits under the company's standard executive severance agreement, and the filing does not state a dollar amount. The change is a senior executive transition with no financial results or guidance included.
Oleg Ryaboy, Chief Technology Officer, departs effective November 2, 2025 and is no longer an executive officer as of October 3, 2025
Marc Kermisch appointed Chief Technology & AI Officer effective October 13, 2025
Kermisch previously served as CTO at Emergent Software and as Global Chief Digital and Information Officer at Case New Holland
Ryaboy's severance follows Section 5(A) of the executive severance agreement filed June 6, 2022
Proto Labs reported record second-quarter 2025 revenue of $135.1 million, up 7.5% from a year earlier, while GAAP net income was $4.4 million, or $0.18 per diluted share, slightly below the prior-year $4.5 million. Non-GAAP EPS rose to $0.41 from $0.38, and the company guided third-quarter 2025 revenue to $130.0 million to $138.0 million, which matters to shareholders because sales grew while reported profit slipped.
Revenue was $135.1 million, up 7.5% from $125.6 million; Protolabs Network revenue rose 18.6% to $29.3 million.
GAAP net income was $4.4 million, or $0.18 per diluted share, versus $4.5 million, or $0.18, in Q2 2024.
Non-GAAP net income was $10.0 million, or $0.41 per diluted share, versus $0.38 in Q2 2024; excluded CEO transition costs were $1.4 million.
Q3 2025 outlook: revenue of $130.0 million to $138.0 million and GAAP diluted EPS of $0.17 to $0.25.
Proto Labs entered a new consulting agreement with Robert Bodor, who ceased to be President and CEO effective May 20, 2025. Under the agreement dated May 28, 2025, Bodor will provide transitional services for a monthly fee of $5,000 through November 11, 2025, subject to him signing a general waiver and release of claims.
Monthly consulting fee of $5,000, with the term running through November 11, 2025
Agreement is conditioned on Bodor signing and not rescinding a general waiver and release of claims
Bodor keeps vested stock options until the agreement ends or he exercises them; unvested options are forfeited, and vested options may be exercised for three months after termination or expiration
Proto Labs' board appointed Suresh Krishna as President and Chief Executive Officer effective May 20, 2025, succeeding Robert Bodor, who left the CEO role and the board. Krishna also joined the board, and the company reaffirmed its second-quarter 2025 outlook. The leadership change is the main news for shareholders, and the company did not change its prior guidance.
Krishna's employment began May 20, 2025; he was CEO of Northern Tool + Equipment from April 2020 to November 2024.
His employment agreement sets an initial base salary of $800,000 and a target bonus of 100% of base salary.
The company reaffirmed Q2 2025 revenue guidance of $124.0 million to $132.0 million and GAAP diluted EPS of $0.11 to $0.19.
Proto Labs reported first quarter 2025 revenue of $126.2 million, down 1.3% from $127.9 million a year earlier, and GAAP diluted earnings of $0.15 per share versus $0.20. Both revenue and per-share profit declined year over year. The company also gave a second quarter 2025 outlook of $124.0 million to $132.0 million in revenue and GAAP diluted EPS of $0.11 to $0.19.
Revenue was $126.2 million, down 1.3% from $127.9 million; Protolabs Network revenue rose 10.0% to $26.3 million
Net income was $3.6 million, or $0.15 per diluted share, versus $5.3 million, or $0.20, a year earlier; non-GAAP diluted EPS was $0.33 versus $0.40
Repurchased $20.9 million of common stock in the quarter; cash and investments were $116.3 million at March 31, 2025
Q2 2025 outlook: revenue of $124.0 million to $132.0 million; GAAP diluted EPS of $0.11 to $0.19
Proto Labs reported fourth quarter 2024 revenue of $121.8 million, down 2.6% from a year earlier, and a net loss of $0.4 million, or $0.02 per diluted share, compared with net income of $7.0 million a year earlier. Full-year revenue was $500.9 million, down 0.6%, and full-year GAAP earnings were $0.66 per diluted share, flat with 2023. The board also approved a $100 million stock repurchase program.
Q4 2024 revenue was $121.8 million, down 2.6% from $125.0 million in Q4 2023; Q4 net loss was $0.4 million, or $(0.02) per diluted share
Full-year 2024 revenue was $500.9 million, down 0.6%; full-year GAAP net income was $16.6 million, or $0.66 per diluted share, versus $0.66 in 2023
Q1 2025 outlook: revenue between $120 million and $128 million; GAAP diluted EPS between $0.08 and $0.16
New $100 million stock repurchase program approved on February 4, 2025, with no obligation to buy a set amount of shares
Proto Labs reported third quarter 2024 revenue of $125.6 million, down 3.9% from $130.7 million a year earlier, with GAAP diluted earnings of $0.29 per share versus $0.31. It also gave a fourth quarter 2024 revenue outlook of $115 million to $123 million and GAAP diluted EPS of $0.10 to $0.18. For shareholders, the headline revenue and profit measures both declined year over year, and the company said it generated $24.8 million in operating cash flow in the quarter.
Q3 2024 revenue was $125.6 million, down 3.9% from $130.7 million in Q3 2023.
Q3 2024 GAAP net income was $7.2 million, or $0.29 per diluted share, versus $8.0 million, or $0.31, a year earlier.
Q3 2024 Adjusted EBITDA was $21.9 million, or 17.4% of revenue, versus $23.9 million, or 18.3%, in Q3 2023.
Q4 2024 outlook: revenue of $115 million to $123 million and GAAP diluted EPS of $0.10 to $0.18.
On October 21, 2024, Proto Labs' board approved a plan to close its prototype injection molding facility in Eschenlohe, Germany, and discontinue Direct Metal Laser Sintering 3D printing services at its Putzbrunn, Germany facility. The company expects total restructuring charges of $4.5 million to $6.0 million and cash expenditures of $3.0 million to $4.0 million, mostly for severance, and says it will keep offering manufacturing services across Europe through internal facilities and partners.
Board approved the plan on October 21, 2024, closing the Eschenlohe injection molding facility and discontinuing 3D printing services at Putzbrunn, Germany.
Total restructuring charges expected at $4.5 million to $6.0 million, including $2.5 million to $3.5 million in severance and $2.0 million to $2.5 million in facility write-downs.
About $4.0 million of the charge expected in the fourth quarter of 2024; total cash expenditures expected at $3.0 million to $4.0 million.
Plan expected to be substantially complete within the next year.
Proto Labs disclosed a settlement agreement with Bjoern Klaas, former Vice President and General Manager of the EMEA region, who left his role in July 2024. His termination date will be November 30, 2024, and he will receive severance, bonus, and equity vesting terms. The filing describes a departure of a former officer, not a change in company leadership or financial results.
Settlement Agreement dated October 1, 2024 among Proto Labs, Proto Labs Germany GmbH and Bjoern Klaas
Termination date set for November 30, 2024
Base salary severance of EUR 299,792, equal to one times annualized base salary
Company waived Klaas' non-compete and non-solicitation obligations and will pay half of his base salary for one year
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Protolabs filing is on SEC EDGAR ↗. 8-K briefs of other companies →